Innovation and Biomarkers in Cancer Drug Development (IBCD 2015) is dedicated to multi-stakeholder approaches to cancer drug development with new cancer biomarkers, including:
Quality assurance and control
Biomarker validation
Regulatory acceptance
The limitations of genomic profiling
Challenges associated with immunological
Interpretation of next generation sequencing results
New challenges for statistics and bioinformatics
Functional and imaging biomarkers
Molecular based clinical research platforms
Regulatory aspects and areas of co-development of drug and assays and co-development of combinations of drugs and assays
Who should Attend
Attendees from industry, regulators and academia.
Past Events
Innovation and Biomarkers in Cancer Drug Development (IBCD 2015) - 03-04 Dec 2015, Square Brussels Meeting Centre, Belgium (32176)
Innovation and Biomarkers in Cancer Drug Development (IBCD) 2026
Important
Please, check "Innovation and Biomarkers in Cancer Drug Development (IBCD)" official website for possible changes, before making any traveling arrangements
Event Categories
Health & Medicine: Oncology, Pharma
Science: Biochemistry, Health sciences, Life Sciences & Biology
